Caldwell Trust CO Laboratory Corp Of America Holdings Transaction History

Caldwell Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 24, 2025	SELL	$192.5 - $216.35 $11,550 - $12,981	-60 Closed	0 $0
Q1 2024 Sep 24, 2025	BUY	$209.01 - $232.56 $12,540 - $13,953	60 New	60 $13.1 Million
Q1 2023 Oct 01, 2025	BUY	$213.32 - $257.83 $12,799 - $15,469	60 New	60 $13.8 Million
Q3 2022 Oct 01, 2025	BUY	$204.81 - $262.19 $12,288 - $15,731	60 New	60 $12.3 Million
Q1 2022 Oct 01, 2025	BUY	$259.82 - $298.18 $15,589 - $17,890	60 New	60 $15.8 Million

Q1 2021 Oct 02, 2025	BUY	$204.88 - $255.03 $12,292 - $15,301	60 New	60 $15.3 Million
Q4 2020 Oct 02, 2025	BUY	$186.91 - $214.42 $11,214 - $12,865	60 New	60 $12.2 Million
Q1 2020 Oct 02, 2025	BUY	$104.32 - $195.28 $6,259 - $11,716	60 New	60 $7.58 Million
Q4 2019 Oct 06, 2025	BUY	$163.48 - $173.61 $9,808 - $10,416	60 New	60 $10.2 Million

1.85M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $23.9B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

Stay updated on Caldwell Trust CO with notifications on news.